How can I safely and confidently use β‑lactam antibiotics such as ceftriaxone in children and adults after a patient experienced moderate anaphylaxis (treated with 0.3 mL subcutaneous adrenaline, pheniramine, and hydrocortisone) following a test dose of about 75 mL ceftriaxone, given that parents often refuse test dosing?

Stop Using Test Doses and Avoid Unnecessary Fear of IV Antibiotics

You should confidently use IV ceftriaxone and other β-lactam antibiotics without routine test dosing in children and adults, as test doses are not recommended and provide no clinical benefit while causing unnecessary pain and delaying appropriate treatment 1, 2, 3.

Why Test Doses Are Not Recommended

The WHO explicitly states: "Routine skin testing before prescribing a beta-lactam antibiotic (e.g. penicillin and amoxicillin) is not needed in children or adults and should not be recommended in guidelines as this is an unnecessary barrier to the use of Access antibiotics" 1. Test doses have no validated predictive value for anaphylaxis and are not part of standard allergy evaluation protocols 2.

Your single experience with anaphylaxis, while understandably concerning, represents the expected rare occurrence—true IgE-mediated β-lactam anaphylaxis occurs in approximately 0.01-0.05% of exposures 4. The FDA label for ceftriaxone acknowledges hypersensitivity reactions can occur but does not recommend test dosing 3.

Understanding Your Patient's Reaction

The reaction you witnessed (rigors after 75mL of ceftriaxone infusion) may not have been true anaphylaxis. Rigors can represent:

• Infusion-related reactions (rate-dependent)
• Fever response to infection
• Non-IgE mediated reactions

True anaphylaxis involves multi-system involvement (skin + respiratory/cardiovascular/GI symptoms) occurring within minutes to 1 hour of exposure 5.

How to Safely Use β-Lactam Antibiotics

For Patients WITHOUT Prior Documented β-Lactam Allergy:

Administer the full therapeutic dose directly without any testing 1, 2. This includes:

• All children requiring antibiotics
• Adults of any age
• IV or oral formulations

For Patients WITH Reported Penicillin Allergy History:

Risk-stratify based on history 4:

Low-risk histories (give ceftriaxone directly without testing):

• Family history only
• Gastrointestinal symptoms alone
• Vague symptoms >10 years ago
• Isolated pruritus without rash
• Non-severe rashes

Moderate-risk histories (can still give ceftriaxone):

• Non-anaphylactic urticaria or rash to penicillin
• Ceftriaxone has a different R1 side chain than penicillin/amoxicillin, so cross-reactivity is <2% 2, 4, 6
• Can administer ceftriaxone by full dose or graded challenge

High-risk histories requiring evaluation:

• Documented anaphylaxis to penicillin (refer for penicillin skin testing before using penicillin, but ceftriaxone can still be given) 2
• Stevens-Johnson syndrome, TEN, DRESS, severe hepatitis, nephritis, hemolytic anemia (avoid all β-lactams) 7, 6

For Patients WITH Prior Ceftriaxone Anaphylaxis:

Avoid ceftriaxone and cephalosporins with identical R1 side chains (cefotaxime shares the same R1 side chain as ceftriaxone) 2, 8. However:

• Other cephalosporins with different R1 side chains (cefazolin, cefuroxime, cefepime) can be used safely 2
• Carbapenems can be administered without testing (cross-reactivity 0.3-0.87%) 2
• Penicillins can be used if penicillin skin testing is negative 2, 9

Practical Management Protocol

Before Administration:

1. Take a focused allergy history: Ask specifically about timing, symptoms, and severity of any prior reactions
2. Ensure emergency equipment is available: Have epinephrine 1:1000 (0.01 mg/kg IM, max 0.3-0.5mg), antihistamines, and IV access ready 3, 10
3. Educate yourself on anaphylaxis recognition: Multi-system involvement within minutes to 1 hour

During Administration:

1. Administer the full dose at standard infusion rates (ceftriaxone over 30 minutes for IV)
2. Observe the patient for 30-60 minutes after first dose completion
3. Do not use test doses—they delay treatment and cause unnecessary pain without providing safety benefit

If Anaphylaxis Occurs:

1. Stop the infusion immediately
2. Give IM epinephrine 0.01 mg/kg (max 0.5mg adults, 0.3mg children) into the mid-outer thigh 10, 5
3. Place patient supine with legs elevated
4. Give antihistamines and corticosteroids as adjuncts (not primary treatment)
5. Observe for 4-6 hours for biphasic reactions (though most occur within 2.5 hours or >10 hours later) 11
6. Refer for formal allergy evaluation with skin testing to identify safe alternatives 9, 12

Key Points to Restore Your Confidence

• True β-lactam anaphylaxis is rare: You will see thousands of uneventful administrations for every reaction 1, 4
• Test doses are not evidence-based: No guideline recommends them; they are a barrier to appropriate care 1, 2
• Cross-reactivity is overestimated: Penicillin-cephalosporin cross-reactivity is <2%, not the 10% historically quoted 4, 6
• Most "penicillin allergies" are not real: >90% of patients with penicillin allergy labels can tolerate penicillins on testing 4, 6
• You can treat anaphylaxis effectively: Your previous successful management proves you can handle reactions if they occur
• Alternative antibiotics cause more harm: Using broad-spectrum alternatives increases MRSA, VRE, C. difficile, surgical site infections, and costs 4, 6

Common Pitfalls to Avoid

1. Don't confuse non-allergic side effects with allergy: Nausea, diarrhea, headache are not allergies
2. Don't assume all rashes are allergic: Many are viral exanthems coinciding with antibiotic use
3. Don't extrapolate one patient's reaction to all patients: Your risk assessment was appropriate; the reaction was a rare event
4. Don't use pain as an excuse for inadequate treatment: Explain to families that test doses are not medically indicated and delay necessary treatment
5. Don't avoid IV antibiotics when indicated: Oral alternatives may be inadequate for serious infections

The evidence strongly supports abandoning test doses and confidently administering appropriate β-lactam antibiotics with standard monitoring 1, 2, 3. Your clinical judgment about when IV antibiotics are "absolutely necessary" should guide antibiotic selection, not fear of rare reactions you are fully equipped to manage.